Dong Qian

1.4k total citations
29 papers, 776 citations indexed

About

Dong Qian is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dong Qian has authored 29 papers receiving a total of 776 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 10 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dong Qian's work include RNA modifications and cancer (9 papers), DNA Repair Mechanisms (5 papers) and Cancer-related molecular mechanisms research (5 papers). Dong Qian is often cited by papers focused on RNA modifications and cancer (9 papers), DNA Repair Mechanisms (5 papers) and Cancer-related molecular mechanisms research (5 papers). Dong Qian collaborates with scholars based in China, United States and Hong Kong. Dong Qian's co-authors include Zhiyong Yuan, Dan Xie, Wenjing Wang, Qi Tian, Xiaoran Long, Wen Di, Keqi Song, Xia Yin, Hao Hu and Jingjing Cheng and has published in prestigious journals such as Clinical Cancer Research, International Journal of Radiation Oncology*Biology*Physics and Molecular Cancer.

In The Last Decade

Dong Qian

29 papers receiving 773 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dong Qian China 18 528 370 171 107 90 29 776
Atsushi Okabe Japan 17 602 1.1× 247 0.7× 239 1.4× 166 1.6× 86 1.0× 40 883
Ajish George United States 10 671 1.3× 312 0.8× 389 2.3× 66 0.6× 156 1.7× 16 1.1k
James R. Hernandez United States 10 379 0.7× 186 0.5× 241 1.4× 86 0.8× 142 1.6× 15 678
Renaud Grépin France 16 601 1.1× 278 0.8× 278 1.6× 154 1.4× 150 1.7× 26 917
Christiane Hader Germany 16 688 1.3× 214 0.6× 150 0.9× 162 1.5× 43 0.5× 19 857
Ondřej Vyčítal Czechia 14 481 0.9× 441 1.2× 339 2.0× 99 0.9× 71 0.8× 43 914
Moitza Principe Italy 10 359 0.7× 228 0.6× 215 1.3× 59 0.6× 115 1.3× 14 599
Zeinab Barekati Switzerland 17 662 1.3× 481 1.3× 239 1.4× 97 0.9× 56 0.6× 23 962
Hongda Lu China 15 441 0.8× 363 1.0× 112 0.7× 118 1.1× 57 0.6× 25 685
Alexander Polyzos United States 14 744 1.4× 188 0.5× 157 0.9× 68 0.6× 149 1.7× 25 952

Countries citing papers authored by Dong Qian

Since Specialization
Citations

This map shows the geographic impact of Dong Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong Qian more than expected).

Fields of papers citing papers by Dong Qian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong Qian. The network helps show where Dong Qian may publish in the future.

Co-authorship network of co-authors of Dong Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Dong Qian. A scholar is included among the top collaborators of Dong Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong Qian. Dong Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Ying, et al.. (2024). CEBPB-mediated upregulation of SERPINA1 promotes colorectal cancer progression by enhancing STAT3 signaling. Cell Death Discovery. 10(1). 219–219. 15 indexed citations
2.
Guo, Zhao-Yu, Pei Jiang, Dong Qian, et al.. (2023). RNF149 Promotes HCC Progression through Its E3 Ubiquitin Ligase Activity. Cancers. 15(21). 5203–5203. 7 indexed citations
3.
Qian, Dong, Huajun Qu, Xinna Deng, et al.. (2021). m6A-induced LINC00958 promotes breast cancer tumorigenesis via the miR-378a-3p/YY1 axis. Cell Death Discovery. 7(1). 27–27. 52 indexed citations
4.
Qian, Dong, Xiaoran Long, Jie Cheng, et al.. (2021). LncRNA GAS5 suppresses ovarian cancer progression by targeting the miR-96-5p/PTEN axis. Annals of Translational Medicine. 9(24). 1770–1770. 24 indexed citations
5.
Zhao, Jingjing, Wencheng Zhang, Puchun Er, et al.. (2020). Concurrent or Sequential Chemoradiotherapy after 3-4 Cycles Induction Chemotherapy for LS-SCLC with Bulky Tumor. Journal of Cancer. 11(17). 4957–4964. 2 indexed citations
6.
Liu, Xiao, Yuhua Lei, Suming Zhou, et al.. (2020). Anti-parasitic effects and toxicity of formalin on the parasite Mesanophrys sp. of the swimming crab Portunus trituberculatus. Experimental Parasitology. 212. 107886–107886. 14 indexed citations
7.
Chen, Xi, Wencheng Zhang, Dong Qian, et al.. (2019). Chemoradiotherapy-Induced CD4+ and CD8+ T-Cell Alterations to Predict Patient Outcomes in Esophageal Squamous Cell Carcinoma. Frontiers in Oncology. 9. 73–73. 15 indexed citations
8.
Long, Xiaoran, Keqi Song, Hao Hu, et al.. (2019). Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis. Journal of Experimental & Clinical Cancer Research. 38(1). 345–345. 103 indexed citations
9.
Kong, Yan, Dong Qian, Hong Ji, et al.. (2019). The Effect of the Leptin and Leptin Receptor Expression on the Efficacy of Neoadjuvant Chemotherapy in Breast Cancer. Medical Science Monitor. 25. 3005–3013. 6 indexed citations
10.
Qian, Dong, Yuwen Wang, Gang Zhao, et al.. (2019). Tumor Remission and Tumor-Infiltrating Lymphocytes During Chemoradiation Therapy: Predictive and Prognostic Markers in Locally Advanced Esophageal Squamous Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 105(2). 319–328. 19 indexed citations
11.
Zhou, Suming, Zhen Tao, Chen Shen, et al.. (2018). β-actin gene expression is variable among individuals and not suitable for normalizing mRNA levels in Portunus trituberculatus. Fish & Shellfish Immunology. 81. 338–342. 19 indexed citations
12.
Wang, Huan-Huan, Dong Qian, Nicholas G. Zaorsky, et al.. (2018). Ablative Hypofractionated Radiation Therapy Enhances Non-Small Cell Lung Cancer Cell Killing via Preferential Stimulation of Necroptosis In Vitro and In Vivo. International Journal of Radiation Oncology*Biology*Physics. 101(1). 49–62. 34 indexed citations
13.
Zhang, Bin, Weiran Liu, Dong Qian, et al.. (2016). Cytokeratin 18 knockdown decreases cell migration and increases chemosensitivity in non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology. 142(12). 2479–2487. 33 indexed citations
14.
Chen, Xiuli, Dong Qian, Jingjing Cheng, et al.. (2016). High expression of Rad51c predicts poor prognostic outcome and induces cell resistance to cisplatin and radiation in non-small cell lung cancer. Tumor Biology. 37(10). 13489–13498. 15 indexed citations
15.
Meng, Maobin, Huan-Huan Wang, Zhiqiang Wu, et al.. (2016). Stereotactic body radiation therapy for patients with recurrent pancreatic adenocarcinoma at the abdominal lymph nodes or postoperative stump including pancreatic stump and other stump. OncoTargets and Therapy. Volume 9. 3985–3992. 18 indexed citations
16.
Qian, Dong, Kailin Chen, Hui‐Lan Rao, et al.. (2015). MicroRNA-374b Suppresses Proliferation and Promotes Apoptosis in T-cell Lymphoblastic Lymphoma by Repressing AKT1 and Wnt-16. Clinical Cancer Research. 21(21). 4881–4891. 55 indexed citations
17.
Cheng, Jingjing, Weiran Liu, Bin Zhang, et al.. (2015). XRCC3 is a promising target to improve the radiotherapy effect of esophageal squamous cell carcinoma. Cancer Science. 106(12). 1678–1686. 21 indexed citations
18.
Meng, Mao-Bin, Huan-Huan Wang, Nicholas G. Zaorsky, et al.. (2014). Targeting pyruvate kinase M2 contributes to radiosensitivity of non-small cell lung cancer cells in vitro and in vivo. Cancer Letters. 356(2). 985–993. 58 indexed citations
19.
20.
Zhang, Jiaxing, Dong Qian, Feng-Wei Wang, et al.. (2012). MicroRNA-29c enhances the sensitivities of human nasopharyngeal carcinoma to cisplatin-based chemotherapy and radiotherapy. Cancer Letters. 329(1). 91–98. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Atsushi Okabe Breakdown of academic impact, for papers by Ajish George Breakdown of academic impact, for papers by James R. Hernandez Breakdown of academic impact, for papers by Renaud Grépin Breakdown of academic impact, for papers by Christiane Hader Breakdown of academic impact, for papers by Ondřej Vyčítal Breakdown of academic impact, for papers by Moitza Principe Breakdown of academic impact, for papers by Zeinab Barekati Breakdown of academic impact, for papers by Hongda Lu Breakdown of academic impact, for papers by Alexander Polyzos
Rankless by CCL
2026